STAAR Surgical Company (STAA)

STAAR Surgical Company Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Net Income	21.35	39.67	27.51	5.91	14.05
Depreciation & Amortization	5.12	4.51	3.64	3.1	3.7
Share-Based Compensation	23.52	20.37	14.61	12.15	10.55
Other Operating Activities	-35.39	-28.83	-1.8	-0.2	-2.5
Operating Cash Flow	14.59	35.72	43.96	20.95	25.8
Operating Cash Flow Growth	-59.14%	-18.76%	109.83%	-18.78%	102.04%
Capital Expenditures	-18.19	-18.11	-13.65	-8.4	-10.1
Change in Investments	92.54	-138.27	0	0	0
Other Investing Activities	-	-	-	-	-0.08
Investing Cash Flow	74.35	-156.38	-13.65	-8.4	-10.18
Share Issuance / Repurchase	9.67	8.42	19.44	20.65	3.46
Debt Issued / Paid	-0.16	-0.13	-1.65	-1.08	-3.31
Other Financing Activities	-2.1	0	0	0	0
Financing Cash Flow	7.42	8.3	17.79	19.57	0.15
Exchange Rate Effect	0.2	-0.86	-0.86	0.37	0.2
Net Cash Flow	96.56	-113.23	47.25	32.49	15.97
Free Cash Flow	-3.59	17.61	30.32	12.55	15.7
Free Cash Flow Growth	-	-41.92%	141.63%	-20.08%	49.21%
Free Cash Flow Margin	-1.11%	6.19%	13.15%	7.68%	10.45%
Free Cash Flow Per Share	-0.07	0.37	0.64	0.28	0.35

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).